{"id":{"repo_id":"mcmaster","oai_identifier":"oai:macsphere.mcmaster.ca:11375/19453"},"canonical_url":"https://search.ndltd.org/etd/mcmaster/oai:macsphere.mcmaster.ca:11375/19453","repository":{"repo_id":"mcmaster","name":"McMaster University","base_url":"https://macsphere.mcmaster.ca/server/oai/request"},"display":{"title":"The Flourous Labelling Strategy: A New Paradigm in Preparing Radiolabelled Compounds in High Effective Specific Activity","abstract":"<p>A new radiolabelling strategy suitable for preparing radioiodinated compounds in high effective specific activity was developed. The core method employs fluorous chemistry in such a manner that unlabelled precursors can be separated from labelled compounds without the use of HPLC purification. The fluorous labelling strategy involved tin-aryl groups in which the substituents off the metal were fluorine rich. Upon reaction with radioiodide and an oxidant, the tin-aryl bond is cleaved. The non-fluorous product could then be separated from the fluorous starting material by fluorous solid-phase extraction (F-SPE).</p> <p>The initial goal of this thesis was to first establish the viability of the fluorous labelling strategy (FLS). To this end, fluorous benzoic acids, 3- and 4- (tris[2-perfluorohexylethyl]stannyl) benzoic acid (m- and p-2.1) were prepared via organozinc derivatives and subsequent hydrolysis. Following direct iodinolysis of m-2.1 using a sub-stoichiometric amount of iodine, the fluorous benzoic acids were treated with Na[1251]1. After purification via fluorous solid-phase extraction, the resulting iodinated benzoic acids (m- and p-2.5) were prepared in 92 and 93 %yield and excellent purity (>98% by HPLC).</p> <p>Next, to demonstrate that the FLS could be used to create libraries of both precursors and labelled compounds, a small collection of benzamides were prepared from fluorous tetrafluorophenyl active esters (m- and p-2.9). An excess of a series of simple amines were added to reaction wells containing one of the two fluorous active esters and the products purified by taking advantage of the non-fluorous nature of the reagents and reaction byproducts. All products, which were fully characterized and their purities verified by HPLC, were subsequently labeled with 1251 in high radiochemical yield (> 85 %), and the products were obtained in greater than 98% radiochemical purity.</p> <p>To demonstrate the applicability of this method clinically relevant radiopharmaceuticals, a fluorous precursor of the radiopharmaceutical metaiodobenzylguanidine (MIBG) was prepared via the fluorous benzylamine, 3-tris[2- perfluorohexylethyl]stannyl) benzylamine (3.3) upon reacting with 1H-pyrazole carboxamidine. Following radioiodination, high purity C251]- and [1231]MIBG were produced in 81±3% and 80% radiochemical yield respectively in less than 20 min without high-performance liquid chromatography (HPLC) purification. The purified product contained less than 1 ppm tin as determined by inductively coupled plasma-mass spectrometry (ICP-MS).</p> <p>Next, the FLS was expanded to include fluorous precursors suitable for reacting with groups common in peptides and proteins for use in bioconjugation reactions. Among these were a fluorous isocyanate (4.1) which was shown to be stable in fluorous solvents for up to 3 weeks, fluorous benzaldehydes (m- and p- 5.1) and a fluorous iodoacetamide (5.3). Following their purification and characterization, these compounds were each reacted with model systems (e.g. amines, amino acids) and were subsequently radioiodinated using Na[1251]1 in good yields ( > 80 %) and in very high purity(> 98 %) as determined by HPLC.</p>","abstract_html":"&lt;p&gt;A new radiolabelling strategy suitable for preparing radioiodinated compounds in high effective specific activity was developed. The core method employs fluorous chemistry in such a manner that unlabelled precursors can be separated from labelled compounds without the use of HPLC purification. The fluorous labelling strategy involved tin-aryl groups in which the substituents off the metal were fluorine rich. Upon reaction with radioiodide and an oxidant, the tin-aryl bond is cleaved. The non-fluorous product could then be separated from the fluorous starting material by fluorous solid-phase extraction (F-SPE).&lt;/p&gt; &lt;p&gt;The initial goal of this thesis was to first establish the viability of the fluorous labelling strategy (FLS). To this end, fluorous benzoic acids, 3- and 4- (tris[2-perfluorohexylethyl]stannyl) benzoic acid (m- and p-2.1) were prepared via organozinc derivatives and subsequent hydrolysis. Following direct iodinolysis of m-2.1 using a sub-stoichiometric amount of iodine, the fluorous benzoic acids were treated with Na[1251]1. After purification via fluorous solid-phase extraction, the resulting iodinated benzoic acids (m- and p-2.5) were prepared in 92 and 93 %yield and excellent purity (&gt;98% by HPLC).&lt;/p&gt; &lt;p&gt;Next, to demonstrate that the FLS could be used to create libraries of both precursors and labelled compounds, a small collection of benzamides were prepared from fluorous tetrafluorophenyl active esters (m- and p-2.9). An excess of a series of simple amines were added to reaction wells containing one of the two fluorous active esters and the products purified by taking advantage of the non-fluorous nature of the reagents and reaction byproducts. All products, which were fully characterized and their purities verified by HPLC, were subsequently labeled with 1251 in high radiochemical yield (&gt; 85 %), and the products were obtained in greater than 98% radiochemical purity.&lt;/p&gt; &lt;p&gt;To demonstrate the applicability of this method clinically relevant radiopharmaceuticals, a fluorous precursor of the radiopharmaceutical metaiodobenzylguanidine (MIBG) was prepared via the fluorous benzylamine, 3-tris[2- perfluorohexylethyl]stannyl) benzylamine (3.3) upon reacting with 1H-pyrazole carboxamidine. Following radioiodination, high purity C251]- and [1231]MIBG were produced in 81±3% and 80% radiochemical yield respectively in less than 20 min without high-performance liquid chromatography (HPLC) purification. The purified product contained less than 1 ppm tin as determined by inductively coupled plasma-mass spectrometry (ICP-MS).&lt;/p&gt; &lt;p&gt;Next, the FLS was expanded to include fluorous precursors suitable for reacting with groups common in peptides and proteins for use in bioconjugation reactions. Among these were a fluorous isocyanate (4.1) which was shown to be stable in fluorous solvents for up to 3 weeks, fluorous benzaldehydes (m- and p- 5.1) and a fluorous iodoacetamide (5.3). Following their purification and characterization, these compounds were each reacted with model systems (e.g. amines, amino acids) and were subsequently radioiodinated using Na[1251]1 in good yields ( &gt; 80 %) and in very high purity(&gt; 98 %) as determined by HPLC.&lt;/p&gt;","abstract_has_math":false,"creators":["Donovan, Amanda C."],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":"Chemistry","school":null,"contributors":[],"advisors":["Valliant, John F."],"committee_chairs":[],"committee_members":[],"year":2010,"date_issued":"2010-02","date_published":"2010-02","updated_at":"2026-11-18T19:38:47Z","subjects":[],"languages":["en"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://doi.org/10.71548/22005"],"render_values":[{"text":"https://doi.org/10.71548/22005","href":"https://doi.org/10.71548/22005","code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/11375/19453","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"http://hdl.handle.net/11375/19453","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://macsphere.mcmaster.ca/server/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Amacsphere.mcmaster.ca%3A11375%2F19453","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Valliant, John F."]},{"key":"dc:contributor.department","label":"Department","values":["Chemistry"]},{"key":"dc:creator","label":"Author","values":["Donovan, Amanda C."]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2016-06-06T21:42:56Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2016-06-06T21:42:56Z"]},{"key":"dc:date.issued","label":"Date","values":["2010-02"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://hdl.handle.net/11375/19453","https://doi.org/10.71548/22005"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Title: The Flourous Labelling Strategy: A New Paradigm in Preparing Radiolabelled Compounds in High Effective Specific Activity, Author: Amanda C. Donovan, Location: Mills"]},{"key":"dc:description.abstract","label":"Abstract","values":["<p>A new radiolabelling strategy suitable for preparing radioiodinated compounds in high effective specific activity was developed. The core method employs fluorous chemistry in such a manner that unlabelled precursors can be separated from labelled compounds without the use of HPLC purification. The fluorous labelling strategy involved tin-aryl groups in which the substituents off the metal were fluorine rich. Upon reaction with radioiodide and an oxidant, the tin-aryl bond is cleaved. The non-fluorous product could then be separated from the fluorous starting material by fluorous solid-phase extraction (F-SPE).</p> <p>The initial goal of this thesis was to first establish the viability of the fluorous labelling strategy (FLS). To this end, fluorous benzoic acids, 3- and 4- (tris[2-perfluorohexylethyl]stannyl) benzoic acid (m- and p-2.1) were prepared via organozinc derivatives and subsequent hydrolysis. Following direct iodinolysis of m-2.1 using a sub-stoichiometric amount of iodine, the fluorous benzoic acids were treated with Na[1251]1. After purification via fluorous solid-phase extraction, the resulting iodinated benzoic acids (m- and p-2.5) were prepared in 92 and 93 %yield and excellent purity (>98% by HPLC).</p> <p>Next, to demonstrate that the FLS could be used to create libraries of both precursors and labelled compounds, a small collection of benzamides were prepared from fluorous tetrafluorophenyl active esters (m- and p-2.9). An excess of a series of simple amines were added to reaction wells containing one of the two fluorous active esters and the products purified by taking advantage of the non-fluorous nature of the reagents and reaction byproducts. All products, which were fully characterized and their purities verified by HPLC, were subsequently labeled with 1251 in high radiochemical yield (> 85 %), and the products were obtained in greater than 98% radiochemical purity.</p> <p>To demonstrate the applicability of this method clinically relevant radiopharmaceuticals, a fluorous precursor of the radiopharmaceutical metaiodobenzylguanidine (MIBG) was prepared via the fluorous benzylamine, 3-tris[2- perfluorohexylethyl]stannyl) benzylamine (3.3) upon reacting with 1H-pyrazole carboxamidine. Following radioiodination, high purity C251]- and [1231]MIBG were produced in 81±3% and 80% radiochemical yield respectively in less than 20 min without high-performance liquid chromatography (HPLC) purification. The purified product contained less than 1 ppm tin as determined by inductively coupled plasma-mass spectrometry (ICP-MS).</p> <p>Next, the FLS was expanded to include fluorous precursors suitable for reacting with groups common in peptides and proteins for use in bioconjugation reactions. Among these were a fluorous isocyanate (4.1) which was shown to be stable in fluorous solvents for up to 3 weeks, fluorous benzaldehydes (m- and p- 5.1) and a fluorous iodoacetamide (5.3). Following their purification and characterization, these compounds were each reacted with model systems (e.g. amines, amino acids) and were subsequently radioiodinated using Na[1251]1 in good yields ( > 80 %) and in very high purity(> 98 %) as determined by HPLC.</p>"]},{"key":"dc:description.degree","label":"Dc Description Degree","values":["Doctor of Philosophy (PhD)"]},{"key":"dc:title","label":"Title","values":["The Flourous Labelling Strategy: A New Paradigm in Preparing Radiolabelled Compounds in High Effective Specific Activity"]},{"key":"others:access_status","label":"Others Access Status","values":["open.access"]}]}],"canonical_facts":{"dc:contributor.advisor":["Valliant, John F."],"dc:contributor.department":["Chemistry"],"dc:creator":["Donovan, Amanda C."],"dc:date.accessioned":["2016-06-06T21:42:56Z"],"dc:date.available":["2016-06-06T21:42:56Z"],"dc:date.issued":["2010-02"],"dc:description":["Title: The Flourous Labelling Strategy: A New Paradigm in Preparing Radiolabelled Compounds in High Effective Specific Activity, Author: Amanda C. Donovan, Location: Mills"],"dc:description.abstract":["<p>A new radiolabelling strategy suitable for preparing radioiodinated compounds in high effective specific activity was developed. The core method employs fluorous chemistry in such a manner that unlabelled precursors can be separated from labelled compounds without the use of HPLC purification. The fluorous labelling strategy involved tin-aryl groups in which the substituents off the metal were fluorine rich. Upon reaction with radioiodide and an oxidant, the tin-aryl bond is cleaved. The non-fluorous product could then be separated from the fluorous starting material by fluorous solid-phase extraction (F-SPE).</p> <p>The initial goal of this thesis was to first establish the viability of the fluorous labelling strategy (FLS). To this end, fluorous benzoic acids, 3- and 4- (tris[2-perfluorohexylethyl]stannyl) benzoic acid (m- and p-2.1) were prepared via organozinc derivatives and subsequent hydrolysis. Following direct iodinolysis of m-2.1 using a sub-stoichiometric amount of iodine, the fluorous benzoic acids were treated with Na[1251]1. After purification via fluorous solid-phase extraction, the resulting iodinated benzoic acids (m- and p-2.5) were prepared in 92 and 93 %yield and excellent purity (>98% by HPLC).</p> <p>Next, to demonstrate that the FLS could be used to create libraries of both precursors and labelled compounds, a small collection of benzamides were prepared from fluorous tetrafluorophenyl active esters (m- and p-2.9). An excess of a series of simple amines were added to reaction wells containing one of the two fluorous active esters and the products purified by taking advantage of the non-fluorous nature of the reagents and reaction byproducts. All products, which were fully characterized and their purities verified by HPLC, were subsequently labeled with 1251 in high radiochemical yield (> 85 %), and the products were obtained in greater than 98% radiochemical purity.</p> <p>To demonstrate the applicability of this method clinically relevant radiopharmaceuticals, a fluorous precursor of the radiopharmaceutical metaiodobenzylguanidine (MIBG) was prepared via the fluorous benzylamine, 3-tris[2- perfluorohexylethyl]stannyl) benzylamine (3.3) upon reacting with 1H-pyrazole carboxamidine. Following radioiodination, high purity C251]- and [1231]MIBG were produced in 81±3% and 80% radiochemical yield respectively in less than 20 min without high-performance liquid chromatography (HPLC) purification. The purified product contained less than 1 ppm tin as determined by inductively coupled plasma-mass spectrometry (ICP-MS).</p> <p>Next, the FLS was expanded to include fluorous precursors suitable for reacting with groups common in peptides and proteins for use in bioconjugation reactions. Among these were a fluorous isocyanate (4.1) which was shown to be stable in fluorous solvents for up to 3 weeks, fluorous benzaldehydes (m- and p- 5.1) and a fluorous iodoacetamide (5.3). Following their purification and characterization, these compounds were each reacted with model systems (e.g. amines, amino acids) and were subsequently radioiodinated using Na[1251]1 in good yields ( > 80 %) and in very high purity(> 98 %) as determined by HPLC.</p>"],"dc:description.degree":["Doctor of Philosophy (PhD)"],"dc:identifier.uri":["http://hdl.handle.net/11375/19453","https://doi.org/10.71548/22005"],"dc:language.iso":["en"],"dc:title":["The Flourous Labelling Strategy: A New Paradigm in Preparing Radiolabelled Compounds in High Effective Specific Activity"],"dc:type":["Thesis"],"others:access_status":["open.access"]},"updated_at":"2026-11-18T19:38:47Z"}